Research Site

Alcabideche 2755-009

1 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Non-Small Cell Lung

Studies at this site

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer — Recruiting now